TY  - CONF

T1  - COMBINING TUMOUR TREATING FIELDS WITH THERAPEUTIC DNA DAMAGE RESPONSE INHIBITORS TO INCREASE POTENCY IN HIGH-GRADE GLIOBLASTOMAS USING CLINICALLY RELEVANT EX-VIVO GLIOMA STEM CELL MODELS.

JO  - NEURO-ONCOLOGY

PY  - 2022/01/01

AU  - Vanderlinden A

AU  - Rominiyi O

AU  - Collis S

AU  - Jones C

AU  - Myers K

AU  - McGarrity-Cottrell C

ED  - 

VL  - 24

SP  - 93

EP  - 93

Y2  - 2024/12/27

ER  -